|
1
|
Segura-Lopez FK, Güitrón-Cantu A and
Torres J: Association between spp. infections and hepatobiliary
malignancies: A review. World J Gastroenterol. 21:1414–1423. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fujimoto A, Totoki Y, Abe T, Boroevich KA,
Hosoda F, Nguyen HH, Aoki M, Hosono N, Kubo M, Miya F, et al:
Whole-genome sequencing of liver cancers identifies etiological
influences on mutation patterns and recurrent mutations in
chromatin regulators. Nat Genet. 44:760–764. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gustavsson B, Carlsson G, Machover D,
Petrelli N, Roth A, Schmoll HJ, Tveit KM and Gibson F: A review of
the evolution of systemic chemotherapy in the management of
colorectal cancer. Clin Colorectal Cancer. 14:1–10. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang C, Guo Y, Wang J and Min Z: Annexin
A2 knockdown inhibits hepatoma cell growth and sensitizes hepatoma
cells to 5-fluorouracil by regulating β-catenin and cyclin D1
expression. Mol Med Rep. 11:2147–2152. 2015.PubMed/NCBI
|
|
5
|
Focaccetti C, Bruno A, Magnani E,
Bartolini D, Principi E, Dallaglio K, Bucci EO, Finzi G, Sessa F,
Noonan DM and Albini A: Effects of 5-fluorouracil on morphology,
cell cycle, proliferation, apoptosis, autophagy and ROS production
in endothelial cells and cardiomyocytes. PLoS One. 10:e01156862015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun HC and Tang ZY: Preventive treatments
for recurrence after curative resection of hepatocellular
carcinoma-a literature review of randomized control trials. World J
Gastroenterol. 9:635–640. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kumar D, Gupta D, Shankar S and Srivastava
RK: Biomolecular characterization of exosomes released from cancer
stem cells: Possible implications for biomarker and treatment of
cancer. Oncotarget. 6:3280–3291. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Abubaker K, Latifi A, Luwor R, Nazaretian
S, Zhu H, Quinn MA, Thompson EW, Findlay JK and Ahmed N: Short-term
single treatment of chemotherapy results in the enrichment of
ovarian cancer stem cell-like cells leading to an increased tumor
burden. Mol Cancer. 12:242013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ma S, Chan KW, Lee TK, Tang KH, Wo JY,
Zheng BJ and Guan XY: Aldehyde dehydrogenase discriminates the
CD133 liver cancer stem cell populations. Mol Cancer Res.
6:1146–1153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jing F, Kim HJ, Kim CH, Kim YJ, Lee JH and
Kim HR: Colon cancer stem cell markers CD44 and CD133 in patients
with colorectal cancer and synchronous hepatic metastases. Int J
Oncol. 46:1582–1588. 2015.PubMed/NCBI
|
|
11
|
Oliver TG, Mercer KL, Sayles LC, Burke JR,
Mendus D, Lovejoy KS, Cheng MH, Subramanian A, Mu D, Powers S, et
al: Chronic cisplatin treatment promotes enhanced damage repair and
tumor progression in a mouse model of lung cancer. Genes Dev.
24:837–852. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chiba T, Kita K, Zheng YW, Yokosuka O,
Saisho H, Iwama A, Nakauchi H and Taniguchi H: Side population
purified from hepatocellular carcinoma cells harbors cancer stem
cell-like properties. Hepatology. 44:240–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Song J, Chang I, Chen Z, Kang M and Wang
CY: Characterization of side populations in HNSCC: Highly invasive,
chemoresistant and abnormal Wnt signaling. PLoS One. 5:e114562010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Latifi A, Abubaker K, Castrechini N, Ward
AC, Liongue C, Dobill F, Kumar J, Thompson EW, Quinn MA, Findlay JK
and Ahmed N: Cisplatin treatment of primary and metastatic
epithelial ovarian carcinomas generates residual cells with
mesenchymal stem cell-like profile. J Cell Biochem. 112:2850–2864.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mannelli G, Magnelli L, Deganello A,
Busoni M, Meccariello G, Parrinello G and Gallo O: Detection of
putative stem cells markers, CD44/CD133, in primary and lymph node
metastases in head and neck squamous cell carcinomas. A preliminary
immunohistochemical and in vitro study. Clin Otolaryngol.
40:312–320. 2015.
|
|
16
|
Arnold KM, Opdenaker LM, Flynn D and
Sims-Mourtada J: Wound healing and cancer stem cells: Inflammation
as a driver of treatment resistance in breast cancer. Cancer Growth
Metastasis. 8:1–13. 2015.PubMed/NCBI
|
|
17
|
Xu ZY, Tang JN, Xie HX, Du YA, Huang L, Yu
PF and Cheng XD: 5-Fluorouracil chemotherapy of gastric cancer
generates residual cells with properties of cancer stem cells. Int
J Biol Sci. 11:284–294. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Alama A, Gangemi R, Ferrini S, Barisione
G, Orengo AM, Truini M, Bello MG and Grossi F: CD133-positive cells
from non-small cell lung cancer show distinct sensitivity to
cisplatin and afatinib. Arch Immunol Ther Exp (Warsz). 63:207–214.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang M, Wang Y and Zhong J: Side
population cells and drug resistance in breast cancer. Mol Med Rep.
11:4297–4302. 2015.PubMed/NCBI
|
|
20
|
Leccia F, Del Vecchio L, Mariotti E, Di
Noto R, Morel AP, Puisieux A, Salvatore F and Ansieau S: ABCG2, a
novel antigen to sort luminal progenitors of BRCA1-breast cancer
cells. Mol Cancer. 13:2132014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guzel E, Karatas OF, Duz MB, Solak M,
Ittmann M and Ozen M: Differential expression of stem cell markers
and ABCG2 in recurrent prostate cancer. Prostate. 74:1498–1505.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feuerhake F, Sigg W, Höfter EA, Dimpfl T
and Welsch U: Immunohistochemical analysis of Bcl-2 and Bax
expression in relation to cell turnover and epithelial
differentiation markers in the non-lactating human mammary gland
epithelium. Cell Tissue Res. 299:47–58. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lv XG, Ji MY, Dong WG, Lei XF, Liu M, Guo
XF, Wang J and Fang C: EBP50 gene transfection promotes
5-fluorouracil-induced apoptosis in gastric cancer cells through
Bax- and Bcl-2-triggered mitochondrial pathways. Mol Med Rep.
5:1220–1226. 2012.PubMed/NCBI
|
|
24
|
Quan M, Wang P, Cui J, Gao Y and Xie K:
The roles of FOXM1 in pancreatic stem cells and carcinogenesis. Mol
Cancer. 12:1592013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bergamaschi A, Madak-Erdogan Z, Kim YJ,
Choi YL, Lu H and Katzenellenbogen BS: The forkhead transcription
factor FOXM1 promotes endocrine resistance and invasiveness in
estrogen receptor-positive breast cancer by expansion of stem-like
cancer cells. Breast Cancer Res. 16:4362014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Teh MT, Gemenetzidis E, Patel D, Tariq R,
Nadir A, Bahta AW, Waseem A and Hutchison IL: FOXM1 induces a
global methylation signature that mimics the cancer epigenome in
head and neck squamous cell carcinoma. PLoS One. 7:e343292012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamashita T, Kitao A, Matsui O, Hayashi T,
Nio K, Kondo M, Ohno N, Miyati T, Okada H, Yamashita T, et al:
Gd-EOB-DTPA-enhanced magnetic resonance imaging and
alpha-fetoprotein predict prognosis of early-stage hepatocellular
carcinoma. Hepatology. 60:1674–1685. 2014. View Article : Google Scholar : PubMed/NCBI
|
